These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24197582)

  • 41. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The impact of comprehensive cardiac rehabilitation in patients up to 55 years old after acute myocardial infarction treated with primary coronary intervention].
    Piestrzeniewicz K; Navarro-Kuczborska N; Bolińska H; Jegier A; Maciejewski M
    Pol Arch Med Wewn; 2004 Mar; 111(3):309-17. PubMed ID: 15230212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
    Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
    J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications.
    Kamke W; Dovifat C; Schranz M; Behrens S; Moesenthin J; Völler H
    Z Kardiol; 2003 Oct; 92(10):869-75. PubMed ID: 14579052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term follow-up after surgical correction of congenital heart disease.
    Gierat-Haponiuk K; Haponiuk I; Szalewska D; Chojnicki M; Jaworski R; Niedoszytko P; Leszczyńska K; Bakuła S
    Kardiol Pol; 2015; 73(4):267-73. PubMed ID: 25371303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death.
    Mezu U; Adelstein E; Jain S; Saba S
    Am J Cardiol; 2011 Sep; 108(5):718-22. PubMed ID: 21640321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomised clinical trial.
    Berg SK; Pedersen PU; Zwisler AD; Winkel P; Gluud C; Pedersen BD; Svendsen JH
    Eur J Cardiovasc Nurs; 2015 Feb; 14(1):34-44. PubMed ID: 24504872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions.
    Lewin RJ; Coulton S; Frizelle DJ; Kaye G; Cox H
    Heart; 2009 Jan; 95(1):63-9. PubMed ID: 18070951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients.
    Karapolat H; Engin C; Eroglu M; Yagdi T; Zoghi M; Nalbantgil S; Durmaz B; Kirazlı Y; Ozbaran M
    Transplant Proc; 2013 Nov; 45(9):3381-5. PubMed ID: 24182820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impacts of Cardiac Rehabilitation Program on Exercise Capacity, Quality of Life, and Functional Status of Coronary Artery Disease Patients with Left Ventricular Dysfunction.
    Sadeghi M; Garakyaraghi M; Taghavi M; Khosravi M; Sarrafzadegan N; Roohafza H
    Rehabil Nurs; 2015; 40(5):305-9. PubMed ID: 24842623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of short-term exercise training in patients following acute myocardial infarction treated with primary percutaneous coronary intervention.
    Andjic M; Spiroski D; Ilic Stojanovic O; Vidakovic T; Lazovic M; Babic D; Ristic A; Mazic S; Zdravkovic M; Otasevic P
    Eur J Phys Rehabil Med; 2016 Jun; 52(3):364-9. PubMed ID: 27324396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The quality of life in implantable cardioverter defibrillator patients.
    Suwanpasak A; Boonyapisit W
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S108-14. PubMed ID: 24772587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.